Dashboard
15 decisions · 15 governed
2
AP
Today — 9 August 2026
15 agent decisions
15 fully evidenced
100%
4
Clinical reviews pending
1 urgent
9
Utilization exceptions
3 above threshold
88.4%
Program quality score
1.2% vs last quarter
Top 15%
Peer benchmark
Regional comparison
Your Clinical Review Queue
Member M-6614 — CAR-T Therapy Authorization
Clinical Review
Urgent
Referred by claims reviewer
Experimental treatment request — $475K estimated cost, requires medical necessity determination and peer review
Utilization Review — Cardiac Rehab Program
Program Review
High Priority
Quarterly
Enterprise Brain flagged utilization 18% above peer benchmark — detailed analysis available
Clinical Policy Update — Obesity Management
Policy
Medium Priority
Due in 7 days
GLP-1 receptor agonist coverage criteria need updating per new AMA guidelines
Provider Outlier Report — Valley Heart Associates
Utilization
Medium Priority
Quarterly
Referral patterns 2.1 standard deviations above peer group — review required
Recent Brain Activity
Utilization analysis — cardiac rehab program
1 hr ago
Benchmarked against 14 peer plans, 3 improvement areas identified
View analysis →
Clinical evidence review — GLP-1 coverage criteria
3 hrs ago
8 clinical studies analyzed, coverage recommendation drafted
View review →
Provider utilization scoring completed
Yesterday
342 providers scored, 7 flagged as outliers
View scores →
Ask the Brain
Query clinical evidence, utilization data, guidelines, or program outcomes
Start Review
Launch a utilization review, clinical policy assessment, or provider analysis
Governance Console
Review all clinical decisions, evidence chains, and audit trails